Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

1.

Galactose treatment in focal segmental glomerulosclerosis.

Trachtman H, Savin VJ.

Pediatr Nephrol. 2014 May;29(5):931. doi: 10.1007/s00467-013-2700-8. Epub 2013 Dec 22. No abstract available.

PMID:
24362723
[PubMed - in process]
2.

Edoxaban versus warfarin in patients with atrial fibrillation.

Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators.

N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19.

PMID:
24251359
[PubMed - indexed for MEDLINE]
Free Article
3.

Fluid flow shear stress over podocytes is increased in the solitary kidney.

Srivastava T, Celsi GE, Sharma M, Dai H, McCarthy ET, Ruiz M, Cudmore PA, Alon US, Sharma R, Savin VA.

Nephrol Dial Transplant. 2014 Jan;29(1):65-72. doi: 10.1093/ndt/gft387. Epub 2013 Oct 28.

PMID:
24166460
[PubMed - in process]
4.

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I; SAVOR-TIMI 53 Steering Committee and Investigators.

N Engl J Med. 2013 Oct 3;369(14):1317-26. doi: 10.1056/NEJMoa1307684. Epub 2013 Sep 2.

PMID:
23992601
[PubMed - indexed for MEDLINE]
Free Article
5.

Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design.

Trachtman H, Vento S, Gipson D, Wickman L, Gassman J, Joy M, Savin V, Somers M, Pinsk M, Greene T.

BMC Nephrol. 2011 Feb 10;12:8. doi: 10.1186/1471-2369-12-8.

PMID:
21310077
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes.

Saleh MA, Boesen EI, Pollock JS, Savin VJ, Pollock DM.

Diabetologia. 2011 Apr;54(4):979-88. doi: 10.1007/s00125-010-2021-4. Epub 2010 Dec 30.

PMID:
21191784
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.

McCarthy ET, Sharma M, Savin VJ.

Clin J Am Soc Nephrol. 2010 Nov;5(11):2115-21. doi: 10.2215/CJN.03800609. Epub 2010 Oct 21. Review.

PMID:
20966123
[PubMed - indexed for MEDLINE]
Free Article
8.

Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat.

Saleh MA, Boesen EI, Pollock JS, Savin VJ, Pollock DM.

Hypertension. 2010 Nov;56(5):942-9. doi: 10.1161/HYPERTENSIONAHA.110.156570. Epub 2010 Sep 7. Erratum in: Hypertension. 2011 Oct;58(4):e31.

PMID:
20823379
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Follow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group.

Peyser A, Machardy N, Tarapore F, Machardy J, Powell L, Gipson DS, Savin V, Pan C, Kump T, Vento S, Trachtman H.

BMC Nephrol. 2010 Jan 29;11:2. doi: 10.1186/1471-2369-11-2.

PMID:
20113498
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The urine proteome for radiation biodosimetry: effect of total body vs. local kidney irradiation.

Sharma M, Halligan BD, Wakim BT, Savin VJ, Cohen EP, Moulder JE.

Health Phys. 2010 Feb;98(2):186-95. doi: 10.1097/HP.0b013e3181b17cbd.

PMID:
20065682
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study group.

Joy MS, Gipson DS, Powell L, MacHardy J, Jennette JC, Vento S, Pan C, Savin V, Eddy A, Fogo AB, Kopp JB, Cattran D, Trachtman H.

Am J Kidney Dis. 2010 Jan;55(1):50-60. doi: 10.1053/j.ajkd.2009.08.019. Epub 2009 Nov 22.

PMID:
19932542
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Plasma "factors" in recurrent nephrotic syndrome after kidney transplantation: causes or consequences of glomerular injury?

Savin VJ, Sharma M.

Am J Kidney Dis. 2009 Sep;54(3):406-9. doi: 10.1053/j.ajkd.2009.06.010. No abstract available.

PMID:
19700061
[PubMed - indexed for MEDLINE]
13.
14.

Cluster analysis of extracardiac control of the heart rate in random-bred albino rats at rest.

Kur'yanova EV, Teplyi DL, Savin VF.

Bull Exp Biol Med. 2009 Jan;147(1):15-8.

PMID:
19526120
[PubMed - indexed for MEDLINE]
15.

8,9-Epoxyeicosatrienoic acid protects the glomerular filtration barrier.

Sharma M, McCarthy ET, Reddy DS, Patel PK, Savin VJ, Medhora M, Falck JR.

Prostaglandins Other Lipid Mediat. 2009 Jun;89(1-2):43-51.

PMID:
19480064
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Antibodies to protein tyrosine phosphatase receptor type O (PTPro) increase glomerular albumin permeability (P(alb)).

Charba DS, Wiggins RC, Goyal M, Wharram BL, Wiggins JE, McCarthy ET, Sharma R, Sharma M, Savin VJ.

Am J Physiol Renal Physiol. 2009 Jul;297(1):F138-44. doi: 10.1152/ajprenal.00122.2008. Epub 2009 Apr 29.

PMID:
19403647
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

ADMA injures the glomerular filtration barrier: role of nitric oxide and superoxide.

Sharma M, Zhou Z, Miura H, Papapetropoulos A, McCarthy ET, Sharma R, Savin VJ, Lianos EA.

Am J Physiol Renal Physiol. 2009 Jun;296(6):F1386-95. doi: 10.1152/ajprenal.90369.2008. Epub 2009 Mar 18.

PMID:
19297451
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The Urine Proteome as a Biomarker of Radiation Injury: Submitted to Proteomics- Clinical Applications Special Issue: "Renal and Urinary Proteomics (Thongboonkerd)"

Sharma M, Halligan BD, Wakim BT, Savin VJ, Cohen EP, Moulder JE.

Proteomics Clin Appl. 2008 Jun 18;2(7-8):1065-1086.

PMID:
19746194
[PubMed]
Free PMC Article
19.

Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity.

Savin VJ, McCarthy ET, Sharma R, Charba D, Sharma M.

Transl Res. 2008 Jun;151(6):288-92. doi: 10.1016/j.trsl.2008.04.001. Epub 2008 May 2.

PMID:
18514139
[PubMed - indexed for MEDLINE]
20.

Serum permeability activity in steroid-resistant minimal change nephrotic syndrome is abolished by treatment of Hodgkin disease.

Aggarwal N, Batwara R, McCarthy ET, Sharma R, Sharma M, Savin VJ.

Am J Kidney Dis. 2007 Nov;50(5):826-9.

PMID:
17954296
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk